Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Fernández-Cancio

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Minerva Endocrinologica|February 26, 2013
Growth hormone deficiency: an updateL Audí, M Fernández-Cancio, N Camats, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 3, 2001
Sources of interference in the use of 2,3-diaminonaphthalene for the fluorimetric determination of nitric oxide synthase activity in biological samplesM Fernández-Cancio, E M Fernández-Vitos, J J Centelles, et al.
Brain Research. Molecular Brain Research|December 4, 2001
Structural requirements of benzodiazepines for the inhibition of pig brain nitric oxide synthaseM Fernández-Cancio, E M Fernández-Vitos, S Imperial, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|December 6, 2008
Vitamin D and growth hormone regulate growth hormone/insulin-like growth factor (GH-IGF) axis gene expression in human fetal epiphyseal chondrocytesM Fernández-Cancio, L Audi, A Carrascosa, et al.
Anales De Pediatria (Barcelona, Spain : 2003)|July 29, 2014
[Plasma vitamin D levels in native and immigrant children under the age of 6 years of different ethnic origins]J M Sánchez Muro, D Yeste Fernández, A Marín Muñoz, et al.
The Journal of Clinical Endocrinology and Metabolism|June 29, 2006
The d3/fl-growth hormone (GH) receptor polymorphism does not influence the effect of GH treatment (66 microg/kg per day) or the spontaneous growth in short non-GH-deficient small-for-gestational-age children: results from a two-year controlled prospective study in 170 Spanish patientsA Carrascosa, C Esteban, R Espadero, et al.
The Journal of Clinical Endocrinology and Metabolism|May 1, 2008
The exon 3-deleted/full-length growth hormone receptor polymorphism does not influence the effect of puberty or growth hormone therapy on glucose homeostasis in short non-growth hormone-deficient small-for-gestational-age children: results from a two-year controlled prospective studyL Audí, A Carrascosa, C Esteban, et al.
The Journal of Clinical Endocrinology and Metabolism|December 28, 2007
The exon 3-deleted/full-length growth hormone receptor polymorphism did not influence growth response to growth hormone therapy over two years in prepubertal short children born at term with adequate weight and length for gestational ageA Carrascosa, L Audí, M Fernández-Cancio, et al.
Hormone Research in Paediatrics|April 4, 2013
Height gain at adult-height age in 184 short patients treated with growth hormone from prepubertal age to near adult-height age is not related to GH secretory status at GH therapy onsetA Carrascosa, L Audí, M Fernández-Cancio, et al.
Hormone Research in Paediatrics|October 27, 2010
Growth hormone secretory status evaluated by growth hormone peak after two pharmacological growth hormone release stimuli did not significantly influence the two-year catch-up growth induced by growth hormone therapy in 318 prepubertal short children with idiopathic growth retardationA Carrascosa, L Audí, M Fernández-Cancio, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Minerva Endocrinologica|February 26, 2013
Growth hormone deficiency: an updateL Audí, M Fernández-Cancio, N Camats, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 3, 2001
Sources of interference in the use of 2,3-diaminonaphthalene for the fluorimetric determination of nitric oxide synthase activity in biological samplesM Fernández-Cancio, E M Fernández-Vitos, J J Centelles, et al.
Brain Research. Molecular Brain Research|December 4, 2001
Structural requirements of benzodiazepines for the inhibition of pig brain nitric oxide synthaseM Fernández-Cancio, E M Fernández-Vitos, S Imperial, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|December 6, 2008
Vitamin D and growth hormone regulate growth hormone/insulin-like growth factor (GH-IGF) axis gene expression in human fetal epiphyseal chondrocytesM Fernández-Cancio, L Audi, A Carrascosa, et al.
Anales De Pediatria (Barcelona, Spain : 2003)|July 29, 2014
[Plasma vitamin D levels in native and immigrant children under the age of 6 years of different ethnic origins]J M Sánchez Muro, D Yeste Fernández, A Marín Muñoz, et al.
The Journal of Clinical Endocrinology and Metabolism|June 29, 2006
The d3/fl-growth hormone (GH) receptor polymorphism does not influence the effect of GH treatment (66 microg/kg per day) or the spontaneous growth in short non-GH-deficient small-for-gestational-age children: results from a two-year controlled prospective study in 170 Spanish patientsA Carrascosa, C Esteban, R Espadero, et al.
The Journal of Clinical Endocrinology and Metabolism|May 1, 2008
The exon 3-deleted/full-length growth hormone receptor polymorphism does not influence the effect of puberty or growth hormone therapy on glucose homeostasis in short non-growth hormone-deficient small-for-gestational-age children: results from a two-year controlled prospective studyL Audí, A Carrascosa, C Esteban, et al.
The Journal of Clinical Endocrinology and Metabolism|December 28, 2007
The exon 3-deleted/full-length growth hormone receptor polymorphism did not influence growth response to growth hormone therapy over two years in prepubertal short children born at term with adequate weight and length for gestational ageA Carrascosa, L Audí, M Fernández-Cancio, et al.
Hormone Research in Paediatrics|April 4, 2013
Height gain at adult-height age in 184 short patients treated with growth hormone from prepubertal age to near adult-height age is not related to GH secretory status at GH therapy onsetA Carrascosa, L Audí, M Fernández-Cancio, et al.
Hormone Research in Paediatrics|October 27, 2010
Growth hormone secretory status evaluated by growth hormone peak after two pharmacological growth hormone release stimuli did not significantly influence the two-year catch-up growth induced by growth hormone therapy in 318 prepubertal short children with idiopathic growth retardationA Carrascosa, L Audí, M Fernández-Cancio, et al.
Pageof 2